Aptevo
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aptevo and other ETFs, options, and stocks.About APVO
Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology.
APVO Key Statistics
Stock Snapshot
As of today, Aptevo(APVO) shares are valued at $1.12. The company's market cap stands at 18.87M, with a P/E ratio of -0.01.
As of 2025-12-12, Aptevo(APVO) stock has fluctuated between $1.10 and $1.17. The current price stands at $1.12, placing the stock +1.8% above today's low and -4.3% off the high.
Aptevo(APVO) shares are trading with a volume of 447.47K, against a daily average of 1.49M.
During the past year, Aptevo(APVO) stock moved between $1.04 at its lowest and $298.00 at its peak.
During the past year, Aptevo(APVO) stock moved between $1.04 at its lowest and $298.00 at its peak.
APVO News
TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...